Parvez Vora
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.
Journal: International journal of cancer
Published: August 05, 2025
Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2023
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Journal: Journal for immunotherapy of cancer
Published: October 25, 2021
Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors.
Journal: Frontiers in immunology
Published: August 26, 2020
Development of a peptide-based delivery platform for targeting malignant brain tumors.
Journal: Biomaterials
Published: December 15, 2019
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Journal: Cell stem cell
Published: March 28, 2019
EPH Profiling of BTIC Populations in Glioblastoma Multiforme Using CyTOF.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 17, 2018
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Journal: Journal of neuro-oncology
Published: October 09, 2018
Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis.
Journal: Cancer research
Published: April 05, 2018
BMI1 is a therapeutic target in recurrent medulloblastoma.
Journal: Oncogene
Published: February 20, 2018
Last Updated: 09/26/2026